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ORIGINAL ARTICLE
Neonatal hypocalcemia is traditionally divided
into early-onset and late-onset forms based on
the age of onset.1 Late-onset neonatal hypocal-
cemia is defined as hypocalcemia occurring after
the age of 3 days. It is usually symptomatic as an
initial manifestation of hypoparathyroidism, vi-
tamin D deficiency, or maternal hyperparathy-
roidism.1–3 The high phosphorus content of infant
milk formula has also been claimed to cause late-
onset neonatal hypocalcemia,4–6 but transient
pseudohypoparathyroidism of neonates has
rarely been reported as a cause.7–10 We therefore
conducted this study to review the medical records
of patients with late-onset neonatal hypocal-
cemia in the last 12 years and to present the clin-
ical data and the natural course of transient
pseudohypoparathyroidism.
Methods
From 1995 to 2006, there were 41 patients youn-
ger than 3 months who were admitted to the
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University Hospital because of hypocalcemia, and
had detailed medical records for analysis. Twenty-
one were classified as late-onset neonatal hypo-
calcemia. The causes included hypomagnesemia
with hypoparathyroidism in nine, idiopathic 
hypoparathyroidism in five, maternal hyperpara-
thyroidism in one, and critical illness with hypo-
calcemia in one. Five patients had hypocalcemia,
hyperphosphatemia, high tubular threshold max-
imum for phosphorus per glomerular filtration
rate (TmP/GFR), and elevated plasma parathyroid
hormone (PTH) levels, which were characteristic
of pseudohypoparathyroidism. Neither consangui-
nity nor family history of neonatal hypocalcemia
was found in these five patients. They also did not
have any history of maternal diabetes mellitus,
neonatal asphyxia, renal insufficiency, rhabdo-
myolysis, blood exchange transfusion, or use of
diuretics and anticonvulsants.
All five patients were fed with infant formula
with a calcium/phosphorus ratio greater than 1.5
before the development of hypocalcemia. There
were no stigmata of Albright hereditary osteody-
strophy, rachitic rosary, or congenital malforma-
tions detected in these patients during physical
examination. All had spontaneous recovery from
pseudohypoparathyroidism. The medical records
of these patients were thoroughly reviewed and
their clinical course was analyzed.
On admission, all five patients had blood
chemistry evaluated, including serum creatinine, 
alkaline phosphatase (ALP), calcium, phosphorus,
magnesium, and intact PTH (iPTH). Twenty-four
hour urine collection was made to determine
urinary calcium excretion, magnesium excretion,
tubular reabsorption of phosphorus (%TRP) and
TmP/GFR, which was calculated by the equation
previously reported.11 Four patients were regularly
followed-up between 2 months and 7 months
(mean, 4.8 months), with serum electrolyte and
plasma iPTH levels monitored during this period.
The fifth patient was lost to follow-up after the
age of 10 days till he was 5 months old.
Results
All five patients were boys and three were prema-
ture (Table 1). Their age at onset of pseudohypopa-
rathyroidism ranged from 4 days to 54 days (mean,
25 days). Three had jitteriness, focal seizures, or
generalized seizures as their initial clinical mani-
festation. No neurologic anomaly was detected in
these cases. The other two were admitted because
of respiratory distress after birth, and laboratory
tests showed asymptomatic hypocalcemia after
the age of 3 days.
None of these patients had evidence of renal
insufficiency (Table 2). Their serum calcium level
was 1.5 ± 0.16 mmol/L, serum phosphorus was
9.6 ± 1.5 mg/dL, and plasma iPTH level was 182 ±
93 pg/mL at diagnosis. Their serum ALP was 983±
672 U/L. Two patients had hypomagnesemia with
hypocalcemia and elevated iPTH levels. Their
serum magnesium levels were 0.5 mmol/L and
0.64 mmol/L, respectively. At that time, their uri-
nary magnesium excretion was 0.03mmol/day and
0.007 mmol/day, respectively. All five patients had
elevated %TRP of 94.8 ± 3.7% and a high TmP/
GFR of 11.5 ± 2.5 mg/dL.
Table 1. Auxological data
Patient Sex
Gestational 
Birth weight (g) Age at onset (d)
Neurologic symptoms
age (wk) and signs
1 Male 40 2500 52 Seizures
2 Male 36 2870 54 Seizures, jitteriness
3 Male 38 3600 7 Seizures
4 Male 35 1900 7 –
5 Male 36 3144 4 –
Mean ± SD 25 ± 26
C.T. Lee, et al
808 J Formos Med Assoc | 2008 • Vol 107 • No 10
Four of the five patients were treated with 
calcium supplementation and infant formula with
low phosphorus content. A magnesium supple-
ment was given to the patients with hypomag-
nesemia. The biochemical data of one of the
asymptomatic patients with hypomagnesemia
(Patient 4) returned to normal limits even with-
out calcium supplementation. Anticonvulsants
were given to the three patients with seizures. All
the medications were discontinued after treatment,
which ranged from 3 to 26 days.
The biochemical data of the four patients who
had regular follow-up were within normal limits
between 25 and 32 days (mean, 28 ± 3 days) after
disease onset. No hypocalcemia was noted in these
patients in the following 4.8 ± 1.9 months of 
follow-up. The last patient (Patient 5) had nor-
mal serum electrolyte levels but elevated plasma
iPTH of 120 pg/mL detected at the age of 10 days.
He was lost to follow-up thereafter and showed
up again at the age of 5 months. He was symptom-
free during this period and his serum electrolyte
levels were all within normal limits.
Discussion
Late-onset neonatal hypocalcemia is an uncom-
mon electrolyte disorder in neonates.1–3 It usu-
ally reflects an underlying pathologic condition,
such as vitamin D deficiency, hypoparathy-
roidism, maternal hyperparathyroidism, and
high dietary phosphorus load. Transient pseudo-
hypoparathyroidism has also been reported as a
cause of late-onset neonatal hypocalcemia. In
this series, 15 out of 21 cases (71%) had hypo-
parathyroidism as the cause of late-onset neonatal
hypocalcemia. Five patients had hypocalcemia,
hyperphosphatemia, high %TRP, high TmP/GFR,
and elevated iPTH levels, which were consistent
with pseudohypoparathyroidism. The laboratory
findings also distinguished these patients from
those with hypoparathyroidism or excessive phos-
phorus ingestion.
All five patients in the present series were
boys. Similarly, five of seven patients reported inT
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the medical literature were male.7–10 Because tran-
sient pseudohypoparathyroidism is seldom re-
ported, the exact reason for the male predominance
is still not well understood. Three of our patients
were premature babies with gestational age be-
tween 35 and 36 weeks. It has been reported that
preterm infants with gestational age more than
34 weeks had a significant renal response to PTH
stimulation.12 Therefore, it is less likely that renal
resistance to PTH in these patients is related to
their prematurity per se. Three of the five patients
had seizures as their initial clinical manifestation,
which is compatible with earlier observations of
increased neuromuscular irritability as the major
initial presentation.7–10 There was a wide range in
terms of age of onset. All of our patients had their
age of onset within 2 months, and three were de-
tected within 1 week. The age of onset reported in
the medical literature was within 20 days of
age.7–10 In our series, those two patients who had
a later onset of the disorder also had more severe
biochemical findings and bone changes than
others. This may imply that they had experienced
a subclinical course for some time before their
neuromuscular irritability was detected.
The laboratory data of the five patients were
similar to those with transient pseudohypopara-
thyroidism previously reported.7,8 In our series,
two patients had elevated serum ALP levels. One
had a bone X-ray examined and prominent pe-
riosteal effects in both femurs were detected.
They also had higher iPTH levels than the other
three patients. Such findings were also noted by
Minagawa et al.8 Impairment of the intercellular
communication between osteoblasts and osteo-
clasts was proposed to explain such phenomena.7,8
Minagawa et al demonstrated that three pa-
tients with transient pseudohypoparathyroidism
had a brisk response of plasma and/or urine cyclic
AMP to PTH infusion, but the phosphate response
to PTH was sluggish compared with the controls.8
One of two cases reported by Fujisawa et al had
similar findings.7 These data suggest that defects
in intracellular signal transduction distal to cyclic
AMP in the kidneys may be one of the underlying
mechanisms. Because all of the cases later recovered
spontaneously, delay in the maturation of renal
development is proposed as the etiology of tran-
sient pseudohypoparathyroidism.
Two patients in the present series had hypomag-
nesemia accompanied by pseudohypoparathy-
roidism. Low urine magnesium excretion in these
two patients suggested the presence of magne-
sium deficiency. It was reported previously that
magnesium deficiency can impair parathyroid fun-
ction,13–15 and hypomagnesemia accompanied by
hypoparathyroidism is a common cause in neona-
tal hypocalcemia.3 Such a cause was noted in nine
out of 21 patients (43%) in this study.
End-organ unresponsiveness to PTH due to
magnesium deficiency has also been reported.16–18
The fact that two patients in this study had elevated
iPTH levels at a time of hypomagnesemic hypo-
calcemia, with one (Patient 4) having complete
recovery after treatment with magnesium supple-
mentation alone, implied that end-organ respon-
siveness to PTH in these two cases was impaired.
It has been suggested that defective signal trans-
duction of G-protein coupled receptors in the PTH
target organ due to magnesium deficiency is respo-
nsible for this end-organ unresponsiveness.17
All of the patients recovered after a period of
treatment with calcium and/or magnesium sup-
plements and reduction of phosphorus intake.
Although prescribing of a vitamin D analog has
been reported,7–10 our patients recovered with-
out treatment with a vitamin D analog. From our
experience, calcium supplementation in infant for-
mula with low phosphorus content is adequate
for the treatment of such patients.
There was a wide variation of time of sponta-
neous recovery in patients with transient pseudo-
hypoparathyroidism. Four patients, who had been
regularly followed-up at our pediatric endocrine
clinic, recovered spontaneously within 32 days
after disease onset. The other one who was lost to
follow-up after the age of 10 days was symptom-free
and had normal serum electrolyte levels at the age
of 5 months. The natural course of these patients
was similar to that reported in the literature.7,8
In summary, transient pseudohypoparathy-
roidism is a rare cause of late-onset hypocalcemia
C.T. Lee, et al
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in neonates and infants. In addition to delayed
renal maturation, magnesium deficiency is another
cause of this disorder. Such a disturbance usually
resolves before 3 months of age.
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